Genovate Biotechnology Co Ltd (4130) — Long-term Investment Intensity
Genovate Biotechnology Co Ltd (4130) has a Long-term Investment Intensity of 28.8% as of September 2019. Long-term investments of NT$469.06 Million represent 28.8% of total assets of NT$1.63 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Genovate Biotechnology Co Ltd (4130) shareholders funds for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Genovate Biotechnology Co Ltd Long-term Investment Intensity (2015–2018)
This chart shows how Genovate Biotechnology Co Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 28.8%, reflecting long-term investments of NT$469.06 Million against total assets of NT$1.63 Billion TWD. Also explore 4130 total assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Genovate Biotechnology Co Ltd (2015–2018)
The table below presents the year-by-year Long-term Investment Intensity for Genovate Biotechnology Co Ltd from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Genovate Biotechnology Co Ltd market cap and net worth.
| Year | LT Investment Intensity | LT Investments (TWD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 33.6% | NT$583.08 Million | NT$1.74 Billion | ▲ +6.3 pp |
| 2017 | 27.2% | NT$556.21 Million | NT$2.04 Billion | ▼ -20.5 pp |
| 2016 | 47.8% | NT$1.26 Billion | NT$2.65 Billion | ▲ +4.2 pp |
| 2015 | 43.5% | NT$1.10 Billion | NT$2.52 Billion | — |